Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?

BJ, Kang; MJ, Cho; JT, Oh; Y, Lee; BJ, Chae; J, Ko

doi:10.1002/hup.779

Public

Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?

Shared by NobleBlocks on Aug 1, 2006 • 12:00 AM UTC

Authors:

Kang BJ

Cho MJ

Oh JT

Abstract

Objectives This study documents the incidences of agranulocytosis and neutropenia, and the patterns of incidence of the side effects of long-term clozapine treatment in order to determine an appropriate time to stop the Clozaril Patient Monitoring System (CPMS).Methods Hematological, demographic, an...

Discussions